Advertisement
Research Article| Volume 21, ISSUE 1-2, P182-194, January 2020

Inflammatory and Neuropathic Gene Expression Signatures of Chemotherapy-Induced Neuropathy Induced by Vincristine, Cisplatin, and Oxaliplatin in C57BL/6J Mice

      Abstract

      Vincristine, oxaliplatin, and cisplatin are commonly prescribed chemotherapeutic agents for the treatment of many tumors. However, a main side effect is chemotherapy-induced peripheral neuropathy (CIPN), which may lead to changes in chemotherapeutic treatment. Although symptoms associated with CIPN are recapitulated by mouse models, there is limited knowledge of how these drugs affect the expression of genes in sensory neurons. The present study carried out a transcriptomic analysis of dorsal root ganglia following vincristine, oxaliplatin, and cisplatin treatment with a view to gain insight into the comparative pathophysiological mechanisms of CIPN. RNA-Seq revealed 368, 295, and 256 differential expressed genes induced by treatment with vincristine, oxaliplatin, and cisplatin, respectively, and only 5 shared genes were dysregulated in all 3 groups. Cell type enrichment analysis and gene set enrichment analysis showed predominant effects on genes associated with the immune system after treatment with vincristine, while oxaliplatin treatment affected mainly neuronal genes. Treatment with cisplatin resulted in a mixed gene expression signature.

      Perspective

      These results provide insight into the recruitment of immune responses to dorsal root ganglia and indicate enhanced neuroinflammatory processes following administration of vincristine, oxaliplatin, and cisplatin. These gene expression signatures may provide insight into novel drug targets for treatment of CIPN.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Pain
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Alcindor T
        • Beauger N
        Oxaliplatin: A review in the era of molecularly targeted therapy.
        Curr Oncol. 2011; 18: 18-25
        • Anand U
        • Otto WR
        • Anand P
        Sensitization of capsaicin and icilin responses in oxaliplatin treated adult rat DRG neurons.
        Mol Pain. 2010; 6: 82
        • Anders S
        • Pyl PT
        • Huber W
        HTSeq—A Python framework to work with high-throughput sequencing data.
        Bioinformatics. 2015; 31: 166-169
        • Barton DL
        • Wos EJ
        • Qin R
        • Mattar BI
        • Green NB
        • Lanier KS
        • Bearden 3rd, JD
        • Kugler JW
        • Hoff KL
        • Reddy PS
        • Rowland Jr., KM
        • Riepl M
        • Christensen B
        • Loprinzi CL
        A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA.
        Support Care Cancer. 2011; 19: 833-841
        • Bellei E
        • Vilella A
        • Monari E
        • Bergamini S
        • Tomasi A
        • Cuoghi A
        • Guerzoni S
        • Manca L
        • Zoli M
        • Pini LA
        Serum protein changes in a rat model of chronic pain show a correlation between animal and humans.
        Sci Rep. 2017; 7: 41723
        • Boyette-Davis J
        • Dougherty PM
        Protection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocycline.
        Exp Neurol. 2011; 229: 353-357
        • Brohee S
        • van Helden J
        Evaluation of clustering algorithms for protein-protein interaction networks.
        BMC Bioinform. 2006; 7: 488
        • Callizot N
        • Andriambeloson E
        • Glass J
        • Revel M
        • Ferro P
        • Cirillo R
        • Vitte PA
        • Dreano M
        Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity.
        Cancer Chemother Pharmacol. 2008; 62: 995-1007
        • Chatterjee S
        • Behnam Azad B
        • Nimmagadda S
        The intricate role of CXCR4 in cancer.
        Adv Cancer Res. 2014; 124: 31-82
        • Coronel MF
        • Sánchez Granel ML
        • Raggio MC
        • Adler NS
        • De Nicola AF
        • Labombarda F
        • González SL
        Temporal changes in the expression of the translocator protein TSPO and the steroidogenic enzyme 5α-reductase in the dorsal spinal cord of animals with neuropathic pain: Effects of progesterone administration.
        Neurosci Lett. 2016; 624: 23-28
        • Dasari S
        • Tchounwou PB
        Cisplatin in cancer therapy: Molecular mechanisms of action.
        Eur J Pharmacol. 2014; 740: 364-378
        • Deuis JR
        • Lim YL
        • de Sousa SR
        • Lewis RJ
        • Alewood PF
        • Cabot PJ
        • Vetter I
        Analgesic effects of clinically used compounds in novel mouse models of polyneuropathy induced by oxaliplatin and cisplatin.
        Neuro Oncol. 2014; 16: 1324-1332
        • Deuis JR
        • Vetter I
        The thermal probe test: A novel behavioral assay to quantify thermal paw withdrawal thresholds in mice.
        Temperature (Austin). 2016; 3: 199-207
        • Deuis JR
        • Zimmermann K
        • Romanovsky AA
        • Possani LD
        • Cabot PJ
        • Lewis RJ
        • Vetter I
        An animal model of oxaliplatin-induced cold allodynia reveals a crucial role for Nav1.6 in peripheral pain pathways.
        Pain. 2013; 154: 1749-1757
        • Di Cesare Mannelli L
        • Pacini A
        • Micheli L
        • Tani A
        • Zanardelli M
        • Ghelardini C
        Glial role in oxaliplatin-induced neuropathic pain.
        Exp Neurol. 2014; 261: 22-33
        • Dobin A
        • Davis CA
        • Schlesinger F
        • Drenkow J
        • Zaleski C
        • Jha S
        • Batut P
        • Chaisson M
        • Gingeras TR
        STAR: Ultrafast universal RNA-seq aligner.
        Bioinformatics. 2013; 29: 15-21
        • Doyle T
        • Chen Z
        • Muscoli C
        • Bryant L
        • Esposito E
        • Cuzzocrea S
        • Dagostino C
        • Ryerse J
        • Rausaria S
        • Kamadulski A
        • Neumann WL
        • Salvemini D
        Targeting the overproduction of peroxynitrite for the prevention and reversal of paclitaxel-induced neuropathic pain.
        J Neurosci. 2012; 32: 6149-6160
        • Faivre S
        • Chan D
        • Salinas R
        • Woynarowska B
        • Woynarowski JM
        DNA strand breaks and apoptosis induced by oxaliplatin in cancer cells.
        Biochem Pharmacol. 2003; 66: 225-237
        • Farguhar-Smith P
        • Brown MRD
        Persistent pain in cancer survivors: Pathogenesis and treatment options.
        Pain Clin Updates. 2016; XXIV: 1-8
        • Ferrier J
        • Pereira V
        • Busserolles J
        • Authier N
        • Balayssac D
        Emerging trends in understanding chemotherapy-induced peripheral neuropathy.
        Curr Pain Headache Rep. 2013; 17: 364
        • Gan PP
        • McCarroll JA
        • Po'uha ST
        • Kamath K
        • Jordan MA
        • Kavallaris M
        Microtubule dynamics, mitotic arrest, and apoptosis: Drug-induced differential effects of betaIII-tubulin.
        Mol Cancer Ther. 2010; 9: 1339-1348
        • Garrison S
        • Hojgaard A
        • Patillo D
        • Weis JJ
        • Weis JH
        Functional characterization of Pactolus, a beta-integrin-like protein preferentially expressed by neutrophils.
        J Biol Chem. 2001; 276: 35500-35511
        • Habib AM
        • Matsuyama A
        • Okorokov AL
        • Santana-Varela S
        • Bras JT
        • Aloisi AM
        • Emery EC
        • Bogdanov YD
        • Follenfant M
        • Gossage SJ
        • Gras M
        • Humphrey J
        • Kolesnikov A
        • Le Cann K
        • Li S
        • Minett MS
        • Pereira V
        • Ponsolles C
        • Sikandar S
        • Torres JM
        • Yamaoka K
        • Zhao J
        • Komine Y
        • Yamamori T
        • Maniatis N
        • Panov KI
        • Houlden H
        • Ramirez JD
        • Bennett DLH
        • Marsili L
        • Bachiocco V
        • Wood JN
        • Cox JJ
        A novel human pain insensitivity disorder caused by a point mutation in ZFHX2.
        Brain. 2018; 141: 365-376
        • Haim N
        • Epelbaum R
        • Ben-Shahar M
        • Yarnitsky D
        • Simri W
        • Robinson E
        Full dose vincristine (without 2-mg dose limit) in the treatment of lymphomas.
        Cancer. 1994; 73: 2515-2519
        • Hosli E
        • Stauffer S
        • Hosli L
        Autoradiographic and electrophysiological evidence for the existence of neurotensin receptors on cultured astrocytes.
        Neuroscience. 1995; 66: 627-633
        • Janes K
        • Esposito E
        • Doyle T
        • Cuzzocrea S
        • Tosh DK
        • Jacobson KA
        • Salvemini D
        A3 adenosine receptor agonist prevents the development of paclitaxel-induced neuropathic pain by modulating spinal glial-restricted redox-dependent signaling pathways.
        Pain. 2014; 155: 2560-2567
        • Janes K
        • Little JW
        • Li C
        • Bryant L
        • Chen C
        • Chen Z
        • Kamocki K
        • Doyle T
        • Snider A
        • Esposito E
        • Cuzzocrea S
        • Bieberich E
        • Obeid L
        • Petrache I
        • Nicol G
        • Neumann WL
        • Salvemini D
        The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1.
        J Biol Chem. 2014; 289: 21082-21097
        • Janes K
        • Wahlman C
        • Little JW
        • Doyle T
        • Tosh DK
        • Jacobson KA
        • Salvemini D
        Spinal neuroimmune activation is independent of T-cell infiltration and attenuated by A3 adenosine receptor agonists in a model of oxaliplatin-induced peripheral neuropathy.
        Brain Behav Immun. 2015; 44: 91-99
        • Jha MK
        • Jeon S
        • Jin M
        • Lee WH
        • Suk K
        Acute phase protein lipocalin-2 is associated with formalin-induced nociception and pathological pain.
        Immune Netw. 2013; 13: 289-294
        • Jing X
        • Wang T
        • Huang S
        • Glorioso JC
        • Albers KM
        The transcription factor Sox11 promotes nerve regeneration through activation of the regeneration-associated gene Sprr1a.
        Exp Neurol. 2012; 233: 221-232
        • Kanei Y
        • Nallu K
        • Makker P
        • Behuria S
        • Fox J
        ST-segment elevation myocardial infarction resulting from stent thrombosis in contemporary real-world practice.
        Int J Angiol. 2017; 26: 32-35
        • Kaplan LD
        • Deitcher SR
        • Silverman JA
        • Morgan G
        Phase II study of vincristine sulfate liposome injection (Marqibo) and rituximab for patients with relapsed and refractory diffuse large B-cell lymphoma or mantle cell lymphoma in need of palliative therapy.
        Clin Lymphoma Myeloma Leuk. 2014; 14: 37-42
        • Kiguchi N
        • Maeda T
        • Kobayashi Y
        • Kishioka S
        Up-regulation of tumor necrosis factor-alpha in spinal cord contributes to vincristine-induced mechanical allodynia in mice.
        Neurosci Lett. 2008; 445: 140-143
        • Koks S
        • Fernandes C
        • Kurrikoff K
        • Vasar E
        • Schalkwyk LC
        Gene expression profiling reveals upregulation of Tlr4 receptors in Cckb receptor deficient mice.
        Behav Brain Res. 2008; 188: 62-70
        • Land SR
        • Kopec JA
        • Cecchini RS
        • Ganz PA
        • Wieand HS
        • Colangelo LH
        • Murphy K
        • Kuebler JP
        • Seay TE
        • Needles BM
        • Bearden 3rd, JD
        • Colman LK
        • Lanier KS
        • Pajon Jr., ER
        • Cella D
        • Smith RE
        • O'Connell MJ
        • Costantino JP
        • Wolmark N
        Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07.
        J Clin Oncol. 2007; 25: 2205-2211
        • Ledeboer A
        • Jekich BM
        • Sloane EM
        • Mahoney JH
        • Langer SJ
        • Milligan ED
        • Martin D
        • Maier SF
        • Johnson KW
        • Leinwand LA
        • Chavez RA
        • Watkins LR
        Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats.
        Brain Behav Immun. 2007; 21: 686-698
        • Li H
        • Handsaker B
        • Wysoker A
        • Fennell T
        • Ruan J
        • Homer N
        • Marth G
        • Abecasis G
        • Durbin R
        • Genome Project Data Processing Subgroup
        The sequence alignment/map format and SAMtools.
        Bioinformatics. 2009; 25: 2078-2079
        • Li D
        • Huang ZZ
        • Ling YZ
        • Wei JY
        • Cui Y
        • Zhang XZ
        • Zhu HQ
        • Xin WJ
        Up-regulation of CX3CL1 via nuclear factor-kappaB-dependent histone acetylation is involved in paclitaxel-induced peripheral neuropathy.
        Anesthesiology. 2015; 122: 1142-1151
        • Lieber S
        • Blankenburg M
        • Apel K
        • Hirschfeld G
        • Hernaiz Driever P
        • Reindl T
        Small-fiber neuropathy and pain sensitization in survivors of pediatric acute lymphoblastic leukemia.
        Eur J Paediatr Neurol. 2018; 22: 457-469
        • Lindå H
        • Sköld MK
        • Ochsmann T
        Activating transcription factor 3, a useful marker for regenerative response after nerve root injury.
        Front Neurol. 2011; 2 (eCollection 2011)
        • Liu CC
        • Lu N
        • Cui Y
        • Yang T
        • Zhao ZQ
        • Xin WJ
        • Liu XG
        Prevention of paclitaxel-induced allodynia by minocycline: Effect on loss of peripheral nerve fibers and infiltration of macrophages in rats.
        Mol Pain. 2010; 6: 76
        • Lomonaco M
        • Milone M
        • Batocchi AP
        • Padua L
        • Restuccia D
        • Tonali P
        Cisplatin neuropathy—Clinical course and neurophysiological findings.
        J Neurol. 1992; 239: 199-204
        • Loprinzi CL
        • Maddocks-Christianson K
        • Wolf SL
        • Rao RD
        • Dyck PJ
        • Mantyh P
        • Dyck PJ
        The paclitaxel acute pain syndrome: Sensitization of nociceptors as the putative mechanism.
        Cancer J. 2007; 13: 399-403
        • Loprinzi CL
        • Reeves BN
        • Dakhil SR
        • Sloan JA
        • Wolf SL
        • Burger KN
        • Kamal A
        • Le-Lindqwister NA
        • Soori GS
        • Jaslowski AJ
        • Novotny PJ
        • Lachance DH
        Natural history of paclitaxel-associated acute pain syndrome: Prospective cohort study NCCTG N08C1.
        J Clin Oncol. 2011; 29: 1472-1478
        • Love MI
        • Huber W
        • Anders S
        Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.
        Genome Biol. 2014; 15: 550
        • Lynds R
        • Lyu C
        • Lyu GW
        • Shi XQ
        • Rosen A
        • Mustafa K
        • Shi TJS
        Neuronal plasticity of trigeminal ganglia in mice following nerve injury.
        J Pain Res. 2017; 10: 349-357
        • Makker PG
        • Duffy SS
        • Lees JG
        • Perera CJ
        • Tonkin RS
        • Butovsky O
        • Park SB
        • Goldstein D
        • Moalem-Taylor G
        Characterisation of immune and neuroinflammatory changes associated with chemotherapy-induced peripheral neuropathy.
        PLoS One. 2017; 12e0170814
        • Martin S
        • Vincent JP
        • Mazella J
        Involvement of the neurotensin receptor-3 in the neurotensin-induced migration of human microglia.
        J Neurosci. 2003; 23: 1198-1205
        • Mechanic JA
        • Sutton JE
        • Berson AE
        • Wu X
        • Kwan J
        • Schreiber R
        • Pang Z
        • Button DC
        Involvement of the neurotensin receptor 1 in the behavioral effects of two neurotensin agonists, NT-2 and NT69L: Lack of hypothermic, antinociceptive and antipsychotic actions in receptor knockout mice.
        Eur Neuropsychopharmacol. 2009; 19: 466-475
        • Meyer L
        • Zuberbier T
        • Worm M
        • Oettle H
        • Riess H
        Hypersensitivity reactions to oxaliplatin: Cross-reactivity to carboplatin and the introduction of a desensitization schedule.
        J Clin Oncol. 2002; 20: 1146-1147
        • Miller LK
        • Hou X
        • Rodriguiz RM
        • Gagnidze K
        • Sweedler JV
        • Wetsel WC
        • Devi LA
        Mice deficient in endothelin-converting enzyme-2 exhibit abnormal responses to morphine and altered peptide levels in the spinal cord.
        J Neurochem. 2011; 119: 1074-1085
        • Nassini R
        • Gees M
        • Harrison S
        • De Siena G
        • Materazzi S
        • Moretto N
        • Failli P
        • Preti D
        • Marchetti N
        • Cavazzini A
        • Mancini F
        • Pedretti P
        • Nilius B
        • Patacchini R
        • Geppetti P
        Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation.
        Pain. 2011; 152: 1621-1631
        • Nazir HF
        • AlFutaisi A
        • Zacharia M
        • Elshinawy M
        • Mevada ST
        • Alrawas A
        • Khater D
        • Jaju D
        • Wali Y
        Vincristine-induced neuropathy in pediatric patients with acute lymphoblastic leukemia in Oman: Frequent autonomic and more severe cranial nerve involvement.
        Pediatr Blood Cancer. 2017; 64: e26677
        • O'Brien S
        • Schiller G
        • Lister J
        • Damon L
        • Goldberg S
        • Aulitzky W
        • Ben-Yehuda D
        • Stock W
        • Coutre S
        • Douer D
        • Heffner LT
        • Larson M
        • Seiter K
        • Smith S
        • Assouline S
        • Kuriakose P
        • Maness L
        • Nagler A
        • Rowe J
        • Schaich M
        • Shpilberg O
        • Yee K
        • Schmieder G
        • Silverman JA
        • Thomas D
        • Deitcher SR
        • Kantarjian H
        High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia.
        J Clin Oncol. 2013; 31: 676-683
        • Old EA
        • Nadkarni S
        • Grist J
        • Gentry C
        • Bevan S
        • Kim KW
        • Mogg AJ
        • Perretti M
        • Malcangio M
        Monocytes expressing CX3CR1 orchestrate the development of vincristine-induced pain.
        J Clin Invest. 2014; 124: 2023-2036
        • Pachman DR
        • Qin R
        • Seisler DK
        • Smith EML
        • Beutler AS
        • Ta LE
        • Lafky JM
        • Wagner-Johnston ND
        • Ruddy KJ
        • Dakhil S
        • Staff NP
        • Grothey A
        • Loprinzi CL
        Clinical course of oxaliplatin-induced neuropathy: Results from the randomized phase III trial N08CB (Alliance).
        J Clin Oncol. 2015; 33: 3416-3422
        • Park JH
        • Chae J
        • Roh K
        • Kil EJ
        • Lee M
        • Auh CK
        • Lee MA
        • Yeom CH
        • Lee S
        Oxaliplatin-induced peripheral neuropathy via TRPA1 stimulation in mice dorsal root ganglion is correlated with aluminum accumulation.
        PLoS One. 2015; 10e0124875
        • Park SB
        • Lin CSY
        • Krishnan AV
        • Goldstein D
        • Friedlander ML
        • Kiernan MC
        Long-term neuropathy after oxaliplatin treatment: Challenging the dictum of reversibility.
        Oncologist. 2011; 16: 708-716
        • Pevida M
        • Lastra A
        • Hidalgo A
        • Baamonde A
        • Menendez L
        Spinal CCL2 and microglial activation are involved in paclitaxel-evoked cold hyperalgesia.
        Brain Res Bull. 2013; 95: 21-27
        • Plummer R
        • Wilson RH
        • Calvert H
        • Boddy AV
        • Griffin M
        • Sludden J
        • Tilby MJ
        • Eatock M
        • Pearson DG
        • Ottley CJ
        • Matsumura Y
        • Kataoka K
        • Nishiya T
        A phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours.
        Br J Cancer. 2011; 104: 593-598
        • Quasthoff S
        • Hartung HP
        Chemotherapy-induced peripheral neuropathy.
        J Neurol. 2002; 249: 9-17
        • Raghavendra V
        • Tanga F
        • DeLeo JA
        Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy.
        J Pharmacol Exp Ther. 2003; 306: 624-630
        • Ramachandran P
        • Pellicoro A
        • Vernon MA
        • Boulter L
        • Aucott RL
        • Ali A
        • Hartland SN
        • Snowdon VK
        • Cappon A
        • Gordon-Walker TT
        • Williams MJ
        • Dunbar DR
        • Manning JR
        • van Rooijen N
        • Fallowfield JA
        • Forbes SJ
        • Iredale JP
        Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis.
        Proc Natl Acad Sci U S A. 2012; 109: E3186-E3195
        • Raymond E
        • Chaney SG
        • Taamma A
        • Cvitkovic E
        Oxaliplatin: A review of preclinical and clinical studies.
        Ann Oncol. 1998; 9: 1053-1071
        • Reuter JA
        • Spacek DV
        • Snyder MP
        High-throughput sequencing technologies.
        Mol Cell. 2015; 58: 586-597
        • Seretny M
        • Currie GL
        • Sena ES
        • Ramnarine S
        • Grant R
        • MacLeod MR
        • Colvin LA
        • Fallon M
        Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis.
        Pain. 2014; 155: 2461-2470
        • Shoemaker JE
        • Lopes TJ
        • Ghosh S
        • Matsuoka Y
        • Kawaoka Y
        • Kitano H
        CTen: A web-based platform for identifying enriched cell types from heterogeneous microarray data.
        BMC Genom. 2012; 13: 460
        • Siegal T
        • Haim N
        Cisplatin-induced peripheral neuropathy. Frequent off-therapy deterioration, demyelinating syndromes, and muscle cramps.
        Cancer. 1990; 66: 1117-1123
        • Starobova H
        • Vetter I
        Pathophysiology of chemotherapy-induced peripheral neuropathy.
        Front Mol Neurosci. 2017; 10: 174
        • Starobova H
        • Himaya SWA
        • Lewis RJ
        • Vetter I
        Transcriptomics in pain research: Insights from new and old technologies.
        Mol Omics. 2018; 14: 389-404
        • Starobova H
        • Mueller A
        • Allavena R
        • Lohman RJ
        • Sweet MJ
        • Vetter I
        Minocycline prevents the development of mechanical allodynia in mouse models of vincristine-induced peripheral neuropathy.
        Front Neurosci. 2019; 13: 653
        • Subramanian A
        • Tamayo P
        • Mootha VK
        • Mukherjee S
        • Ebert BL
        • Gillette MA
        • Paulovich A
        • Pomeroy SL
        • Golub TR
        • Lander ES
        • Mesirov JP
        Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles.
        Proc Natl Acad Sci U S A. 2005; 102: 15545-15550
        • Szklarczyk D
        • Franceschini A
        • Wyder S
        • Forslund K
        • Heller D
        • Huerta-Cepas J
        • Simonovic M
        • Roth A
        • Santos A
        • Tsafou KP
        • Kuhn M
        • Bork P
        • Jensen LJ
        • von Mering C
        STRING v10: Protein-protein interaction networks, integrated over the tree of life.
        Nucleic Acids Res. 2015; 43: D447-D452
        • Tedder TF
        • Engel P
        CD20: A regulator of cell-cycle progression of B lymphocytes.
        Immunol Today. 1994; 15: 450-454
        • Thibault K
        • Rivals I
        • M'Dahoma S
        • Dubacq S
        • Pezet S
        • Calvino B
        Structural and molecular alterations of primary afferent fibres in the spinal dorsal horn in vincristine-induced neuropathy in rat.
        J Mol Neurosci. 2013; 51: 880-892
        • Thibault K
        • Riviere S
        • Lenkei Z
        • Ferezou I
        • Pezet S
        Orofacial neuropathic pain leads to a hyporesponsive barrel cortex with enhanced structural synaptic plasticity.
        PLoS One. 2016; 11e0160786
        • Verstappen CC
        • Koeppen S
        • Heimans JJ
        • Huijgens PC
        • Scheulen ME
        • Strumberg D
        • Kiburg B
        • Postma TJ
        Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening.
        Neurology. 2005; 64: 1076-1077
        • Wang H
        • Jin Y
        • Dai J
        Biological processes and pathway changes in isoflurane-induced anesthesia revealed by bioinformatics analysis of gene expression profiles.
        J Anesth. 2015; 29: 912-919
        • Wang XM
        • Lehky TJ
        • Brell JM
        • Dorsey SG
        Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy.
        Cytokine. 2012; 59: 3-9
        • Wilson RH
        • Lehky T
        • Thomas RR
        • Quinn MG
        • Floeter MK
        • Grem JL
        Acute oxaliplatin-induced peripheral nerve hyperexcitability.
        J Clin Oncol. 2002; 20: 1767-1774
        • Xu T
        • Zhang XL
        • Ou-Yang HD
        • Li ZY
        • Liu CC
        • Huang ZZ
        • Xu J
        • Wei JY
        • Nie BL
        • Ma C
        • Wu SL
        • Xin WJ
        Epigenetic upregulation of CXCL12 expression mediates antitubulin chemotherapeutics-induced neuropathic pain.
        Pain. 2017; 158: 637-648
        • Yamamoto K
        • Chiba N
        • Chiba T
        • Kambe T
        • Abe K
        • Kawakami K
        • Utsunomiya I
        • Taguchi K
        Transient receptor potential ankyrin 1 that is induced in dorsal root ganglion neurons contributes to acute cold hypersensitivity after oxaliplatin administration.
        Mol Pain. 2015; 11: 69
        • Yin K
        • Deuis JR
        • Lewis RJ
        • Vetter I
        Transcriptomic and behavioural characterisation of a mouse model of burn pain identify the cholecystokinin 2 receptor as an analgesic target.
        Mol Pain. 2016; 12: 1-13
        • Zhang H
        • Li Y
        • de Carvalho-Barbosa M
        • Kavelaars A
        • Heijnen CJ
        • Albrecht PJ
        • Dougherty PM
        Dorsal root ganglion infiltration by macrophages contributes to paclitaxel chemotherapy-induced peripheral neuropathy.
        J Pain. 2016; 17: 775-786
        • Zhang H
        • Yoon SY
        • Zhang H
        • Dougherty PM
        Evidence that spinal astrocytes but not microglia contribute to the pathogenesis of paclitaxel-induced painful neuropathy.
        J Pain. 2012; 13: 293-303
        • Zhao M
        • Isami K
        • Nakamura S
        • Shirakawa H
        • Nakagawa T
        • Kaneko S
        Acute cold hypersensitivity characteristically induced by oxaliplatin is caused by the enhanced responsiveness of TRPA1 in mice.
        Mol Pain. 2012; 8: 55
        • Zwelling LA
        • Anderson T
        • Kohn K W
        DNA-protein and DNA interstrand cross-linking by cis- and trans-platinum(II) diamminedichloride in L1210 mouse leukemia cells and relation to cytotoxicity.
        Cancer Res. 1979; 39: 365-369